Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Luciferin is the generic name for a class of light-emitting substrates used in bioluminescent reactions. In nature, luciferins are oxidized in the presence of the enzyme luciferase and oxygen, resulting in the formation of oxyluciferin and the emission of visible light. The exact structure of luciferin varies widely among organisms—major types in nature include firefly luciferin, coelenterazine, cypridina luciferin, and bacterial luciferin. Each bioluminescent system (e.g., firefly, jellyfish, deep-sea shrimp, bacteria) uses a specific luciferin-luciferase pair. Luciferins are widely employed as substrates in biochemical assays and molecular imaging due to their efficient light production and nontoxic properties.
Substrate for luciferase enzyme; undergoes oxidation to produce oxyluciferin and light
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Luciferin.